In addition, curcumin inhibits α-synuclein aggregation, thereby preventing the loss of dopaminergic neurons.797,798 Our laboratory established a curcumin-siSNCA vector platform for the gene-chem synergistic treatment of PD. Here, SNCA is linked to Parkinson disease.